πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

AXIM Biotechnologies Patents

Full USPTO pharma patent portfolio for AXIM Biotechnologies β€” grant dates, expiration, and drug cross-links.

Patents
138
Expiring ≀24m
3

Quick answer

AXIM Biotechnologies has 138 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 3

  1. US 10434117

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10408834

    Mutated parvovirus structural proteins as vaccines

    Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10293037

    DNA vaccine for use in pancreatic cancer patients

    Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10272051

    Method to treat atopic dermatitis

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10261095

    Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10253294

    Galactose oxidase treatment of dendritic cells to improve their immunogenicity

    Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10172786

    Oral care composition comprising cannabinoids

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10105414

    Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10092538

    Suppositories comprising cannabinoids

    Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10071966

    Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10028974

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10010571

    Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat, metabolic rate, and weight loss, and methods of use thereof

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9957329

    Factor XII inhibitors for the treatment of neurological inflammatory disorders

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9920297

    Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9844530

    Ophthalmic solutions for glaucoma and conjunctivitis treatment

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9839684

    Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9814789

    Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9814695

    Ophthalmic solutions for glaucoma and conjunctivitis treatment

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9801938

    Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9750717

    Inhibitors of CD40-TRAF6 interaction

    Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9718811

    (S)-enantiomer of mepazine

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9678061

    Identification of T cell target antigens

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9663788

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9658230

    Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB

    Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9624274

    Mutated structural protein of a parvovirus

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9526803

    Diagnostic chewing gum for pathogens

    Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9521845

    Beta-lactones as antibacterial agents

    Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9493738

    Method for producing high yield attenuated Salmonella strains

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9422365

    Peptide or arrangement of peptides forming a Staphylococcus aureus epitope binding site

    Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9415098

    DNA vaccine for use in pancreatic cancer patients

    Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9415087

    Compositions and methods for treating coronavirus infection

    Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9408829

    Inhibitors of CD40-TRAF6 interaction

    Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9260511

    Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB

    Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9220722

    Microrna (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9155778

    Tripeptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SgIt1

    Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9062095

    Mutant double cyclized receptor peptides inhibiting Ξ²1-adrenoceptor antibodies

    Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8906870

    MicroRNA (miRNA) for the diagnosis and treatment of heart diseases

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8889425

    Means and methods for the determination of camp in vitro and in vivo

    Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8877718

    Antiinfective and antitumoral compounds isolated from tropical lianas

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8796428

    Erk1/2 posphorylation site specific antibody

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8716030

    Means for the inhibition of anti-Ξ²1-adrenergic receptor antibodies

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8715682

    Means for the inhibition of anti-beta1-adrenergic receptor antibodies

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8703987

    Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8691783

    MicroRNA-24

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8669283

    Beta-lactones as antibacterial agents

    Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8623614

    Method for the recombinant production of magnetic nanoparticles

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8609102

    Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of ISAA or ISAB

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8592389

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does AXIM Biotechnologies have?

138 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do AXIM Biotechnologies patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.